A new “life-extending” drug has been recommended for use via the NHS to treat women with breast cancer, in a move campaigners have hailed as a “momentous milestone”.
The National Institute for Health and Care Excellence (Nice) has recommended the drug, Trodelvy, should be given to women with triple-negative breast cancer – a highly aggressive form of the disease which is tricky to find treatments for.
